Source: https://alexberenson.substack.com/p/another-day-another-junk-vaccine

= = =

There’s science. And there’s The Science.

Never the twain shall meet.

Last week, the Washington Post pretended Dr. Jay Bhattacharya, director of the National Institutes of Health had hidden a study showing how awesomely awesome mRNA Covid boosters are. In reality, anyone with a basic understanding of statistics and medicine could see the study wasn’t worth the pixels it was printed on.

Now the New York Times is baying the Food and Drug Administration is sitting on studies proving the mRNA Covid jabs are safer than a parachutist jumping from the bottom bunk onto a padded floor, a well-done steak, Dr. Albert Bourla’s pay package at Pfizer, insert your own analogy here…

To wit, the Times just ran this headline: F.D.A. Blocked Publication of Research Finding Covid and Shingles Vaccines Were Safe

To which I offer my own headline: Make It Stop

. . .

The fact that the legacy media and health bureaucrats inside the federal government are still carrying water for mRNAs Covid jabs, should astonish all of us. There is no reasonable case for anyone, even adults over 75, to continue taking these.

1: They don’t work.

2: Covid is extremely mild at this point.

3: We have no idea what the short- or long-term side effects of annual or biannual mRNA injections might be.

Yet — five years on — the mRNA fanatics still won’t quit. They simply cannot admit the truth, no matter how much damage they do to their credibility.

Credibility loss. Maybe we should add that to the list of mRNA side effects.

= = =

Phoenix I agree with your comments about mRNA covid boosters and I don't take them. I don't anyway trust mRNA vaccines at all and would always avoid these.

However, IMO not all vaccines are bad. I'm invested in an immunotherapy Company, Scancell Ltd, that is successfully making DNA based vaccines for cancer - Phase 2 results showing an 80% improvement over the 'Standard of Care' for advanced melanoma, (in conjunction with 'Checkpoint Inhibitors').

And iSCIB1+ is a needle-free 'jab' so that's nice !

Here's some recent words from the CEO on 'Fast Track' status being awarded by the FDA recently - " Dr Phil L'Huillier, CEO of Scancell, said: "This designation is a major achievement for Scancell and important recognition not only of the potential of iSCIB1+, but also of the significant need for new and improved treatment options for patients with advanced melanoma. We are very pleased with how the Phase 2 SCOPE data is maturing and are advancing plans for a global registrational Phase 3 trial, which we expect to initiate in the second half of 2026." Progression free survival (PFS) has matured positively, reaching 77% at 20 months in the target population1. This widens the lead of iSCIB1+ over PFS reported with ipilimumab plus nivolumab alone of 43% at 20 months, now representing a 30+ percentage point improvement over standard of care (SoC).[2] The Fast Track Designation is granted for investigational therapies that show advantage over available treatments, such as superior effectiveness, and provides the process to expedite review of drugs for serious conditions, with the aim of getting effective therapies to patients faster.  The designation enables frequent engagement to ensure alignment on development plans, enhance development predictability and support a more efficient path through clinical development. Moreover, Fast Track Designation brings eligibility for Accelerated Approval, Priority Review and Rolling Review.

Additional PFS data and early OS data from the Phase 2 SCOPE study are expected in H1 2027."

One to watch maybe. ATB

And as usual the majority of comments on Alex Berenson's article are also to the point, like this dialogue: